MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$131,147K
Cash and cash
equivalents
$65,300K
Prepaid expenses and
other current assets
$4,328K
Accounts receivable
$1,761K
Related party
collaboration receivable
$151K
Total current assets
$202,687K
Operating lease
right-of-use assets
$28,478K
Property and equipment,
net
$13,136K
Marketable securities
$5,244K
Restricted cash
$2,736K
Total assets
$252,281K
Total liabilities and
stockholders' equity
$252,281K
Total stockholders'
equity
$196,081K
Total liabilities
$56,200K
Accumulated deficit
-$445,905K
Additional paid-in capital
$641,895K
Operating lease
liabilities, net of current...
$28,659K
Total current
liabilities
$26,541K
Other non-current
liabilities
$1,000K
Common stock, 0.001 par
value 120,000,000...
$59K
Accumulated other
comprehensive income (loss)
$32K
Accrued expenses
$12,098K
Operating lease
liabilities
$7,840K
Accounts payable
$5,013K
Deferred revenue
$1,590K
Back
Back
Balance Sheet
source: myfinsight.com
Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (VYGR)